AZD5363+Olaparib+Durvalumab
MC01/01/18
Phase 1 small_molecule active
Quick answer
AZD5363+Olaparib+Durvalumab for Solid Tumor, Adult is a Phase 1 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Solid Tumor, Adult
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active